Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Tuberous Sclerosis × Cannabidiol × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Active not recruiting 2

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 2 Seizures 1 Liver Cirrhosis 1 Lennox Gastaut Syndrome 1 Epilepsies, Myoclonic 1 Behavior 1

Interventions

Everolimus 2 Cannabidiol 2 Doxycycline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05044819 2026-03-17

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05864846 2026-03-12

EpiCom

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡